FLOLAN

General medicines

Product information:

Health-care Professional Information:

  • March 27, 2024 – Notification on FLOLAN (epoprostenol sodium) 0.5 mg/vial (DIN 02230845) and 1.5 mg/vial (DIN 02230848) with regards to changes on the use conditions of the reconstituted solution
  • March 5, 2018 - Important safety information (PDF - 221 KB) from GSK on FLOLAN (epoprostenol sodium) used with polyethylene terephlalate (PET) or polyethylene terephthalate glycol (PETG) Administration Sets
  • July 27, 2016 - Important safety information (PDF - 3.2 MB) from GSK on FLOLAN (epoprostenol sodium): Administration with a reformulated diluent.
  • April 19, 2013 - Important safety information (PDF - 671 KB) regarding the use of FLOLAN.

Patient information:

  • April 24, 2013 - Important information (PDF - 658 KB) for patients regarding the use of FLOLAN.